What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Pathology, Breast cancer, Carcinoma, Cancer research and Internal medicine are his primary areas of study.
His Pathology study incorporates themes from Metaplastic carcinoma and Adenocarcinoma.
The Breast cancer study combines topics in areas such as Basal and Gene expression profiling.
The study incorporates disciplines such as Ductal carcinoma, Renal cell carcinoma, Clear cell renal cell carcinoma and Myoepithelial cell in addition to Carcinoma.
Puay Hoon Tan has included themes like Cell growth, Carcinogenesis, Immunology, Exon and Cyclin D1 in his Cancer research study.
As a part of the same scientific family, Puay Hoon Tan mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Breast cancer classification, Breast disease, Lymphovascular invasion, Cancer cell and Disease.
His most cited work include:
- The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
- The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia (680 citations)
- Breast cancer prognostic classification in the molecular era: the role of histological grade (455 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Pathology, Breast cancer, Internal medicine, Immunohistochemistry and Oncology.
In his research on the topic of Pathology, Malignancy is strongly related with Ductal carcinoma.
His study in Breast cancer is interdisciplinary in nature, drawing from both Cancer research and Metastasis.
His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis and Immunology.
Puay Hoon Tan does research in Immunohistochemistry, focusing on Anatomical pathology specifically.
His Oncology study frequently draws connections to adjacent fields such as Disease.
He most often published in these fields:
- Pathology (55.38%)
- Breast cancer (38.37%)
- Internal medicine (29.86%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (29.86%)
- Pathology (55.38%)
- Breast cancer (38.37%)
In recent papers he was focusing on the following fields of study:
Puay Hoon Tan spends much of his time researching Internal medicine, Pathology, Breast cancer, Oncology and Cancer research.
His Pathology study combines topics from a wide range of disciplines, such as Ductal carcinoma and Core biopsy.
He combines subjects such as Carcinoma and Disease with his study of Ductal carcinoma.
His studies in Breast cancer integrate themes in fields like Immunofluorescence, Cell, Tissue microarray and Treatment response.
The concepts of his Oncology study are interwoven with issues in Chemotherapy, Immune system, Metastasis, Cytokeratin and Triple-negative breast cancer.
His research in Cancer research intersects with topics in Carcinogenesis and Cancer.
Between 2016 and 2021, his most popular works were:
- Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. (89 citations)
- The 2019 World Health Organization classification of tumours of the breast. (63 citations)
- Higher densities of Foxp3 + regulatory T cells are associated with better prognosis in triple-negative breast cancer (53 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Oncology, Internal medicine, Breast cancer, Pathology and Cancer.
His Oncology research includes elements of Immune system, Metastasis, Triple-negative breast cancer, Antibody and Cohort.
His Breast cancer research incorporates elements of Polygenic risk score, Transcriptome and Treatment response.
His studies deal with areas such as Cell and Cyclin D1 as well as Pathology.
His Cancer research includes themes of Cancer research, MED12, Gene expression profiling, TNFAIP3 and CFLAR.
His research integrates issues of Carcinoma and Myoepithelial cell in his study of Ductal carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
